| Literature DB >> 24952767 |
Dongyoung Shin, Ayse Civana, Carolina Acevedo, Chelsea T Smartt1.
Abstract
BACKGROUND: Understanding mechanisms that contribute to viral dissemination in mosquito vectors will contribute to our ability to interfere with the transmission of viral pathogens that impact public health. The expression of genes in two Culex pipiens quinquefasciatus populations from Florida with known differences in vector competence to West Nile virus (WNV) were compared using high throughput sequencing.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24952767 PMCID: PMC4092223 DOI: 10.1186/1471-2164-15-513
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
WNV titer in pooled mosquitoes from two populations (Vero Beach vs Gainesville) of
| Population | Initial dose in bloodmeal (log PFU/ml) | Freshly fed (log PFU/ml) | 5 days post infection (log PFU/ml) |
|---|---|---|---|
| CQV (Vero Beach) | 5.3 | 3.7 | 5.4 |
| CQG (Gainesville) | 5.3 | 3.9 | 5.2 |
Titers were determined in mosquitoes (n = 6) that were either freshly fed or collected 5 days post-infection. WNV titer was also determined in the blood that was provided to the mosquitoes.
Mapping summary
| Population | Replicate | Total reads 1 | No. transcripts 2 |
|---|---|---|---|
| Vero beach | V1 | 70545050 | 14559 |
| V2 | 71274514 | 14119 | |
| V3 | 78569077 | 14887 | |
| Gainesville | G1 | 72080828 | 15328 |
| G2 | 47154902 | 15139 | |
| G3 | 83180408 | 14370 |
1Total number of sequences reads.
2Number of the annotated transcripts in Culex quinquefasciatus (Vectorbase) assembled with the sequence reads.
List of differentially expressed genes between two populations related to WNV infection
| Transcript ID | Description | log2 (fold change)* |
|---|---|---|
| CPIJ019915-RA | alpha-glucosidase, putative | 6.13 |
| CPIJ019847-RA | ubiquinol-cytochrome c reductase complex 14 kDa protein | 5.12 |
| CPIJ005240-RA | latent nuclear antigen, putative | 4.20 |
| CPIJ004426-RA | conserved hypothetical protein | 4.19 |
| CPIJ003600-RA | ctl transporter, putative | 4.18 |
| CPIJ009603-RA | proto-oncogene tyrosine-protein kinase abl1 | 3.80 |
| CPIJ017964-RA | trypsin 7 precursor | 3.69 |
| CPIJ020286-RA | isoleucyl tRNA synthetase, putative | 3.43 |
| CPIJ010313-RA | conserved hypothetical protein | 3.24 |
| CPIJ013626-RA | conserved hypothetical protein | 3.07 |
| CPIJ011888-RA | carbamoyl-phosphate synthase large chain | 3.06 |
| CPIJ014553-RA | salivary long D7 protein 3 | 2.78 |
| CPIJ800101-RA | long form D7clu1 salivary protein | 2.66 |
| CPIJ015241-RA | alkaline phosphatase | 2.64 |
| CPIJ019718-RA | conserved hypothetical protein | 2.62 |
| CPIJ005238-RA | conserved hypothetical protein | 2.55 |
| CPIJ014551-RA | D7 protein precursor | 2.44 |
| CPIJ002236-RA | hypothetical protein | 2.41 |
| CPIJ801512-RA | cat eye syndrome critical region protein 1 precursor | 2.41 |
| CPIJ800099-RA | 7.7 kDa salivary cysteine-rich peptide | 2.37 |
| CPIJ008464-RA | hypothetical protein | 2.20 |
| CPIJ012065-RA | tryptophan transporter | 2.18 |
| CPIJ018241-RA | microsomal glutathione S-transferase 1 | 2.13 |
| CPIJ802576-RA | conserved hypothetical protein | 2.13 |
| CPIJ003205-RA | hypothetical protein | 2.12 |
| CPIJ005906-RA | conserved hypothetical protein | 2.09 |
| CPIJ008471-RA | hypothetical protein | 2.09 |
| CPIJ019221-RA | hypothetical protein | 2.08 |
| CPIJ015059-RA | conserved hypothetical protein | 2.06 |
| CPIJ000835-RA | chymotrypsin-2 | 2.04 |
| CPIJ014970-RA | niemann-Pick C1 protein precursor | 2.02 |
| CPIJ800222-RA | cytochrome P450 | 2.02 |
| CPIJ003807-RA | allantoinase | 2.01 |
| CPIJ002103-RA | conserved hypothetical protein | 2.00 |
| CPIJ018300-RA | salivary secreted antigen-5 precursor AG5-3 | 1.94 |
| CPIJ018735-RA | D7 protein | 1.93 |
| CPIJ016362-RA | alpha-glucosidase precursor | 1.93 |
| CPIJ018565-RA | peptide methionine sulfoxide reductase | 1.88 |
| CPIJ014550-RA | long form D7Bclu1 salivary protein | 1.86 |
| CPIJ018736-RA | D7 protein, putative | 1.86 |
| CPIJ008977-RA | pyridoxal phosphate phosphatase | 1.84 |
| CPIJ007820-RA | actin binding | 1.81 |
| CPIJ017499-RA | hypothetical protein | 1.79 |
| CPIJ015057-RA | conserved hypothetical protein | 1.77 |
| CPIJ003982-RA | hypothetical protein | 1.72 |
| CPIJ002681-RA | glutathione S-transferase | 1.72 |
| CPIJ020056-RA | cysteine dioxygenase | 1.69 |
| CPIJ002737-RA | MPA2 allergen | 1.69 |
| CPIJ014970-RA | niemann-Pick C1 protein precursor | 1.68 |
| CPIJ002367-RA | conserved hypothetical protein | 1.68 |
| CPIJ003807-RA | allantoinase | 1.68 |
| CPIJ002668-RA | hypothetical protein | 1.65 |
| CPIJ001247-RA | conserved hypothetical protein | 1.64 |
| CPIJ007379-RA | hypothetical protein | 1.63 |
| CPIJ011998-RA | zinc carboxypeptidase A 1 precursor | 1.63 |
| CPIJ019944-RA | hypothetical protein | 1.61 |
| CPIJ010456-RA | cysteine dioxygenase | 1.58 |
| CPIJ800096-RA | 41.9 kDa basic salivary protein | 1.58 |
| CPIJ016041-RA | hypothetical protein | 1.54 |
| CPIJ005910-RA | 7.8 kDa basic salivary peptide, putative | 1.54 |
| CPIJ012398-RA | histone H3 type 2 | 1.54 |
| CPIJ005741-RA | calmodulin-binding protein trpl | 1.53 |
| CPIJ010799-RA | carboxypeptidase B | 1.50 |
| CPIJ015715-RA | AMP dependent ligase, putative | 1.47 |
| CPIJ005463-RA | salivary lipase | 1.47 |
| CPIJ800229-RA | cytochrome P450 17A1 | 1.46 |
| CPIJ016921-RA | 3-oxoacyl-[acyl-carrier-protein] reductase 1 | 1.46 |
| CPIJ006975-RA | vacuolar ATP synthase subunit g | 1.46 |
| CPIJ015700-RA | aquaporin | 1.45 |
| CPIJ011388-RA | diazepam binding inhibitor, putative | 1.44 |
| CPIJ016922-RA | serine 3-dehydrogenase | 1.40 |
| CPIJ003185-RA | gamma-glutamyltranspeptidase 1 precursor | 1.39 |
| CPIJ005064-RA | alpha-amylase precursor | 1.37 |
| CPIJ005786-RA | actin-2 | 1.37 |
| CPIJ800225-RA | cytochrome P450 | 1.34 |
| CPIJ015103-RA | trypsin-5 precursor | 1.30 |
| CPIJ010421-RA | 60S ribosomal protein L24 | 1.24 |
| CPIJ003274-RA | vacuolar proton translocating ATPase 116 kDa subunit a isoform 1 | -1.30 |
| CPIJ015839-RA | conserved hypothetical protein | -1.45 |
| CPIJ802157-RA | nuclear hormone receptor FTZ-F1 beta | -1.61 |
| CPIJ010767-RA | hypothetical protein | -1.64 |
| CPIJ009700-RA | conserved hypothetical protein | -1.64 |
| CPIJ800076-RA | small calcium-binding mitochondrial carrier, putative | -1.64 |
| CPIJ015292-RA | zinc-finger protein DPF3 | -1.68 |
| CPIJ008221-RA | conserved hypothetical protein | -1.69 |
| CPIJ800015-RA | Gustatory Receptor | -1.74 |
| CPIJ015294-RA | dopamine receptor, invertebrate | -1.77 |
| CPIJ800292-RA | cytochrome P450 2A12 | -1.80 |
| CPIJ010701-RA | cecropin | -1.85 |
| CPIJ015936-RA | hypothetical protein | -2.05 |
| CPIJ006159-RA | glutathione-requiring prostaglandin D synthase | -2.10 |
| CPIJ016495-RA | thrombospondin-4, putative | -2.16 |
| CPIJ010699-RA | cecropin A | -2.18 |
| CPIJ016128-RA | conserved hypothetical protein | -2.23 |
| CPIJ017192-RA | conserved hypothetical protein | -2.24 |
| CPIJ005518-RA | conserved hypothetical protein | -2.26 |
| CPIJ003470-RA | hypothetical protein | -2.37 |
| CPIJ010191-RA | vitellogenin-A1 precursor | -2.45 |
| CPIJ000056-RA | larval serum protein 1 beta chain precursor | -2.54 |
| CPIJ010516-RA | phosphoenolpyruvate carboxykinase | -2.56 |
| CPIJ005941-RA | ADP, ATP carrier protein 2 | -2.57 |
| CPIJ010190-RA | vitellogenin-A1 precursor | -2.64 |
| CPIJ001820-RA | larval serum protein 2 precursor | -2.89 |
| CPIJ009033-RA | arylphorin subunit C223 precursor | -2.89 |
| CPIJ001822-RA | larval serum protein 2 precursor | -2.91 |
| CPIJ003588-RA | ubiquitin | -3.00 |
| CPIJ009506-RA | hexamerin 2 beta | -3.05 |
| CPIJ007783-RA | arylphorin subunit alpha precursor | -3.05 |
| CPIJ010552-RA | cyclin d | -3.11 |
| CPIJ010700-RA | putative 4.2 kda basic salivary peptide | -3.12 |
| CPIJ002311-RA | conserved hypothetical protein | -3.32 |
| CPIJ013252-RA | conserved hypothetical protein | -3.57 |
| CPIJ010553-RA | cyclin d | -3.68 |
| CPIJ014871-RA | uridine cytidine kinase i | -4.26 |
| CPIJ008969-RA | conserved hypothetical protein | -4.81 |
| CPIJ013631-RA | conserved hypothetical protein | -5.35 |
| CPIJ009149-RA | conserved hypothetical protein | -5.92 |
| CPIJ008969-RA | conserved hypothetical protein | -7.51 |
*Fold change is the gene expression level change in Gainesville population after WNV infection compared to Vero Beach population log CQG/CQV.
Figure 1Validation of the expression of transcripts between two populations by qRT-PCR. *< 0.05. **< 0.01.
Figure 2Functional characterization of significantly differentially expressed transcripts between two populations. *UP are up-regulated genes in CQG; Down are down-regulated.
Over-represented functions in the differentially expressed genes between two populations
| GO term ID | Bonferroni p value | Functional description |
|---|---|---|
| GO:0000786 | 0 | nucleosome |
| GO:0003779 | 0 | actin binding |
| GO:0004180 | 0 | carboxypeptidase activity |
| GO:0004611 | 0 | phosphoenolpyruvate carboxykinase activity |
| GO:0004613 | 0 | phosphoenolpyruvate carboxykinase (GTP) activity |
| GO:0004871 | 0 | signal transducer activity |
| GO:0005215 | 0 | transporter activity |
| GO:0005344 | 0 | oxygen transporter activity |
| GO:0005525 | 0 | GTP binding |
| GO:0005634 | 0 | nucleus |
| GO:0005856 | 0 | cytoskeleton |
| GO:0006122 | 0 | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0006207 | 0 | ‘de novo’ pyrimidine base biosynthetic process |
| GO:0006418 | 0 | tRNA aminoacylation for protein translation |
| GO:0006810 | 0 | transport |
| GO:0007155 | 0 | cell adhesion |
| GO:0008081 | 0 | phosphoric diester hydrolase activity |
| GO:0008121 | 0 | ubiquinol-cytochrome-c reductase activity |
| GO:0008236 | 0 | serine-type peptidase activity |
| GO:0015293 | 0 | symporter activity |
| GO:0015629 | 0 | actin cytoskeleton |
| GO:0016020 | 0 | membrane |
| GO:0016471 | 0 | vacuolar proton-transporting V-type ATPase complex |
| GO:0016705 | 0 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0016791 | 0 | phosphatase activity |
| GO:0016874 | 0 | ligase activity |
| GO:0016888 | 0 | endodeoxyribonuclease activity, producing 5′-phosphomonoesters |
| GO:0019239 | 0 | deaminase activity |
| GO:0043169 | 0 | cation binding |
| GO:0046439 | 0 | L-cysteine metabolic process |
| GO:0050911 | 0 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019538 | 1.87E-26 | protein metabolic process |
| GO:0043401 | 1.38E-19 | steroid hormone mediated signaling pathway |
| GO:0004181 | 9.68E-19 | metallocarboxypeptidase activity |
| GO:0016798 | 1.05E-17 | hydrolase activity, acting on glycosyl bonds |
| GO:0005694 | 5.90E-11 | chromosome |
| GO:0005216 | 1.30E-10 | ion channel activity |
| GO:0006811 | 4.37E-10 | ion transport |
| GO:0005886 | 1.89E-08 | plasma membrane |
| GO:0005549 | 5.39E-08 | odorant binding |
| GO:0006468 | 7.46E-08 | protein phosphorylation |
| GO:0055085 | 6.75E-07 | transmembrane transport |
| GO:0005488 | 4.67E-05 | binding |
| GO:0007165 | 6.23E-05 | signal transduction |
| GO:0016740 | 0.00016076 | transferase activity |
| GO:0004872 | 0.00019634 | receptor activity |
| GO:0016491 | 0.000216583 | oxidoreductase activity |
| GO:0046872 | 0.004430445 | metal ion binding |
| GO:0003824 | 0.040931204 | catalytic activity |
The list of isoform differences between two populations determined by transcript start site and splicing
| Locus | Description | log2 (fold-change) | p-value |
|---|---|---|---|
| TSS | |||
| CPIJ010552 | Cyclin d | −3.11246 | 1.89E-06 |
| CPIJ010553 | Cyclin d | −3.67618 | 3.57E-08 |
| CPIJ010767 | Hypothetical protein | −1.63552 | 1.66E-06 |
| CPIJ001247 | Conserved hypothetical protein | 1.63872 | 2.17E-05 |
| CPIJ013252 | Conserved hypothetical protein | −3.5691 | 3.93E-06 |
| CPIJ014249 | Adenosine deaminase | 2.90642 | 3.83E-05 |
| CPIJ014553 | Salivary long D7 protein 3 | 2.7805 | 2.88E-05 |
| CPIJ019718 | Conserved hypothetical protein | 2.61949 | 8.63E-07 |
| CPIJ020286 | Isoleucyl tRNA synthetase, putative | 3.42754 | 3.73E-05 |
| CPIJ002737 | MPA2 allergen | 1.68586 | 4.67E-06 |
| CPIJ003615 | Salivary protein | 2.6373 | 9.62E-06 |
| CPIJ005240 | Latent nuclear antigen, putative | 4.20007 | 2.17E-06 |
| CPIJ008546 | Predicted protein | −2.95674 | 8.30E-06 |
| Splicing | |||
| CPIJ017916 | Pdz | 0.233522 | 1.00E-05 |
| CPIJ009271 | Vitellogenin | 0.832555 | 1.00E-05 |
| CPIJ009662 | Tripartite | 0.832555 | 1.00E-05 |
TSS: transcript start site.
Figure 3Ovary growth after blood feeding. Standard deviation is calculated from replicated samples tested at each time point and shows significantly different growth rates (ANOVA, p < 0.001). Vero = CQV; GN = CQG; ctrl = control.